Suppr超能文献

钙调磷酸酶或肌苷单磷酸脱氢酶抑制剂对诺如病毒复制具有中度至强大的抗病毒活性。

Inhibition of Calcineurin or IMP Dehydrogenase Exerts Moderate to Potent Antiviral Activity against Norovirus Replication.

机构信息

Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, The Netherlands.

Medical Faculty, Kunming University of Science and Technology, Kunming, People's Republic of China.

出版信息

Antimicrob Agents Chemother. 2017 Oct 24;61(11). doi: 10.1128/AAC.01095-17. Print 2017 Nov.

Abstract

Norovirus is a major cause of acute gastroenteritis worldwide and has emerged as an important issue of chronic infection in transplantation patients. Since no approved antiviral is available, we evaluated the effects of different immunosuppressants and ribavirin on norovirus and explored their mechanisms of action by using a human norovirus (HuNV) replicon-harboring model and a surrogate murine norovirus (MNV) infectious model. The roles of the corresponding drug targets were investigated by gain- or loss-of-function approaches. We found that the calcineurin inhibitors cyclosporine (CsA) and tacrolimus (FK506) moderately inhibited HuNV replication. Gene silencing of their cellular targets, cyclophilin A, FKBP12, and calcineurin, significantly inhibited HuNV replication. A low concentration, therapeutically speaking, of mycophenolic acid (MPA), an uncompetitive IMP dehydrogenase (IMPDH) inhibitor, potently and rapidly inhibited norovirus replication and ultimately cleared HuNV replicons without inducible resistance following long-term drug exposure. Knockdown of the MPA cellular targets IMPDH1 and IMPDH2 suppressed HuNV replication. Consistent with the nucleotide-synthesizing function of IMPDH, exogenous guanosine counteracted the antinorovirus effects of MPA. Furthermore, the competitive IMPDH inhibitor ribavirin efficiently inhibited norovirus and resulted in an additive effect when combined with immunosuppressants. The results from this study demonstrate that calcineurin phosphatase activity and IMPDH guanine synthase activity are crucial in sustaining norovirus infection; thus, they can be therapeutically targeted. Our results suggest that MPA shall be preferentially considered immunosuppressive medication for transplantation patients at risk of norovirus infection, whereas ribavirin represents as a potential antiviral for both immunocompromised and immunocompetent patients with norovirus gastroenteritis.

摘要

诺如病毒是全球急性胃肠炎的主要病因,并且已成为移植患者慢性感染的重要问题。由于没有批准的抗病毒药物,我们评估了不同免疫抑制剂和利巴韦林对诺如病毒的影响,并通过使用人诺如病毒(HuNV)复制子载体模型和替代鼠诺如病毒(MNV)感染模型来探索其作用机制。通过增益或缺失功能方法研究了相应药物靶点的作用。我们发现钙调神经磷酸酶抑制剂环孢菌素(CsA)和他克莫司(FK506)适度抑制 HuNV 复制。其细胞靶标亲环素 A、FKBP12 和钙调神经磷酸酶的基因沉默显著抑制 HuNV 复制。在治疗方面,低浓度的霉酚酸(MPA),一种非竞争性 IMP 脱氢酶(IMPDH)抑制剂,能够迅速且强有力地抑制诺如病毒复制,并在长期药物暴露后没有诱导耐药性的情况下最终清除 HuNV 复制子。MPA 的细胞靶标 IMPDH1 和 IMPDH2 的敲低抑制 HuNV 复制。与 IMPDH 的核苷酸合成功能一致,外源性鸟嘌呤抵消了 MPA 的抗诺如病毒作用。此外,竞争性 IMPDH 抑制剂利巴韦林有效地抑制了诺如病毒,并且当与免疫抑制剂联合使用时具有相加作用。本研究结果表明,钙调神经磷酸酶活性和 IMPDH 鸟嘌呤合酶活性对维持诺如病毒感染至关重要;因此,它们可以作为治疗靶点。我们的研究结果表明,MPA 应优先考虑作为有诺如病毒感染风险的移植患者的免疫抑制药物,而利巴韦林则代表一种针对免疫功能低下和免疫功能正常的诺如病毒胃肠炎患者的潜在抗病毒药物。

相似文献

引用本文的文献

本文引用的文献

2
Global Economic Burden of Norovirus Gastroenteritis.诺如病毒肠胃炎的全球经济负担
PLoS One. 2016 Apr 26;11(4):e0151219. doi: 10.1371/journal.pone.0151219. eCollection 2016.
7
What is the reservoir of emergent human norovirus strains?新兴人类诺如病毒株的储存宿主是什么?
J Virol. 2015 Jun;89(11):5756-9. doi: 10.1128/JVI.03063-14. Epub 2015 Mar 18.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验